title: Predictors of patient survival in continuous ambulatory peritoneal dialysis: 10-year experience in 2 major centers in Tehran.
abstract: BACKGROUND
  Many factors have been proposed to be associated with higher mortality in patients on continuous ambulatory peritoneal dialysis (CAPD). However, the relative importance of these factors may differ among patients with different characteristics. We evaluated survival of patients on CAPD and its influencing factors in Iran.
  
  
  METHODS
  We enrolled 282 patients on CAPD between 1996 and 2006 at 2 major CAPD centers in Tehran. Patient survival was investigated during this period. Demographic characteristics, laboratory data, dialysis adequacy parameters, residual renal function, peritoneal transport characteristics, and nutritional status were assessed as potential predictors of the outcome.
  
  
  RESULTS
  The mean duration of follow-up was 18.4 +/- 14.5 months. Sixty patients (21%) died during the studied period. In univariate analysis, age, body mass index, history and duration of hemodialysis before CAPD, diabetes mellitus, blood pressure, patient selection criteria, edema, peritonitis, renal residual function, urine volume, dialysis adequacy, and serum levels of cholesterol, triglyceride, intact parathyroid hormone, calcium, and albumin were predictors of patient survival. Multivariate analysis demonstrated that old age, diabetes mellitus, prior hemodialysis longer than 7 months, low serum albumin, calcium, trigelyceride, and parathyroid hormone levels independently predicted mortality, while the use of angiotensin-converting enzyme inhibitors was associated with a better survival.
  
  
  CONCLUSIONS
  This study showed that older patients on CAPD and diabetics are at a higher risk of mortality. On the other hand, nutritional and metabolic factors are other predictors of mortality. Especial concern should be applied to good nutrition and treatment of comorbidities in these patients.
authors.affiliation: Department of Internal Medicine and Nephrology, Dr Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran. hakemi@ams.ac.ir
authors.forename: Monir Sadat
authors.initials: MS
authors.lastname: Hakemi
authors.forename: Mehdi
authors.initials: M
authors.lastname: Golbabaei
authors.forename: Amirahmad
authors.initials: A
authors.lastname: Nassiri
authors.forename: Mandana
authors.initials: M
authors.lastname: Kayedi
authors.forename: Mostafa
authors.initials: M
authors.lastname: Hosseini
authors.forename: Shahnaz
authors.initials: S
authors.lastname: Atabak
authors.forename: Mohammad Reza
authors.initials: MR
authors.lastname: Ganji
authors.forename: Manouchehr
authors.initials: M
authors.lastname: Amini
authors.forename: Fereshteh
authors.initials: F
authors.lastname: Saddadi
authors.forename: Iraj
authors.initials: I
authors.lastname: Najafi
mesh_terms: D000328:Adult; D017677:Age Distribution; D002118:Calcium / Q000097:blood; D015897:Comorbidity; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007492:Iran / Q000453:epidemiology; D007676:Kidney Failure, Chronic / Q000097:blood / Q000401:mortality* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D010281:Parathyroid Hormone / Q000097:blood; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000401:mortality*; D010538:Peritonitis / Q000401:mortality; D011237:Predictive Value of Tests; D006435:Renal Dialysis / Q000401:mortality; D012307:Risk Factors; D012709:Serum Albumin / Q000378:metabolism; D016019:Survival Analysis; D014280:Triglycerides / Q000097:blood; D014505:Urban Population / Q000706:statistics & numerical data*
chemical_list: D010281:Parathyroid Hormone; D012709:Serum Albumin; D014280:Triglycerides; D002118:Calcium